Day 2 - SGT / Singapore
Cross-border partnerships between Asia and the West continue to reshape the future of healthcare innovation, investment, and commercial growth. As biotech and medtech companies increasingly look beyond regional markets, strategic collaboration has become critical for scaling globally, accessing capital, and accelerating innovation. This keynote explores how APAC organisations are navigating international expansion, global partnerships, and evolving investment dynamics within an increasingly interconnected and increasingly complex global healthcare environment.
- What separates successful cross-border partnerships from unsuccessful ones?
- How are APAC healthcare companies balancing regional strength with global expansion?
- How are shifting geopolitical dynamics, diverging regulatory environments, regional investment priorities, and evolving market access strategies reshaping cross-border collaboration?
- Where are new global capital sources and partnership opportunities emerging across healthcare and life sciences?
The US remains the largest and most lucrative market for medtech innovation, but entering this competitive landscape requires a tailored approach. This session will provide Asia Pacific startups with actionable strategies to navigate the complexities of scaling in the US, from regulatory hurdles to building strategic partnerships.
Understanding the unique dynamics of the US medtech market for APAC startups
Establishing partnerships with local stakeholders to accelerate market entry
Overcoming regulatory and reimbursement challenges to ensure compliance and success
- Varun Turlapati - Managing Director, Chaankaya Capital
The EMEA region offers diverse opportunities for Asia Pacific medtech startups, with its mix of mature and emerging markets. However, the realities of expansion in the region are stark. This panel will explore the most common pitfalls for APAC medtech companies in EMEA and how APAC innovators can use the region as a growth engine
Identifying which EMEA markets are best for APAC medtech startups
Building cross-border collaborations to drive market penetration
Addressing regulatory, reimbursement and distribution challenges
- Vadim Shpak - Managing Director, Vickers Venture Partners
AI is revolutionizing medtech, driving innovation in diagnostics, treatment, and patient care. This session will spotlight funding trends, ROI potential, and strategies for scaling AI-driven medtech solutions.
Current funding trends for AI in medtech
Measuring ROI and impact of AI-driven solutions
Scaling AI technologies in medtech for global impact